Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
41.45 HKD | -0.36% | +15.56% | -15.27% |
04-30 | Keymed Biosciences' Allergy Treatment NDA Accepted by NMPA | MT |
04-29 | Keymed Biosciences Allergy Drug Achieves Phase III Clinical Trial End Points | MT |